Cargando…

Optimising pharmacotherapy in older cancer patients with polypharmacy

OBJECTIVE: Polypharmacy is frequent among older cancer patients and increases the risk of potential drug‐related problems (DRPs). DRPs are associated with adverse drug events, drug‐drug interactions and hospitalisations. Since no standardised polypharmacy assessment methods for oncology patients exi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vrijkorte, Elze, de Vries, Jennifer, Schaafsma, Ron, Wymenga, Machteld, Oude Munnink, Thijs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063689/ https://www.ncbi.nlm.nih.gov/pubmed/31692151 http://dx.doi.org/10.1111/ecc.13185

Ejemplares similares

Identification and evaluation of cases of polypharmacy and irrational pharmacotherapy in Georgia
por: Gabunia, L, et al.
Publicado: (2023)

TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer
por: Strassl, Irene, et al.
Publicado: (2023)

PB2688: OPIOID USE REDUCTION BY OXYCODONE MORPHINE FORMULARY SWITCH
por: Hazenberg, Carin, et al.
Publicado: (2023)

Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2023)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
por: Roberts, Bradley, et al.
Publicado: (2023)

Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients
por: Chen, Li‐Ju, et al.
Publicado: (2021)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Polypharmacy in Older Adults with Alzheimer’s Disease
por: Esumi, Satoru, et al.
Publicado: (2022)

Computed Tomography‐Based Body Composition Is Not Consistently Associated with Outcome in Older Patients with Colorectal Cancer
por: Looijaard, Stéphanie M.L.M., et al.
Publicado: (2019)

Cobicistat as a Potential Booster of Ponatinib and Dasatinib Exposure in a CML Patient: A Case Study
por: Hofman, Susan, et al.
Publicado: (2023)

Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy
por: Rieckert, Anja, et al.
Publicado: (2018)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Pharmacokinetic Boosting of Kinase Inhibitors
por: Westra, Niels, et al.
Publicado: (2023)

Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review
por: Turk, Amadea, et al.
Publicado: (2022)

Pharmacotherapy for Insomnia Disorder in Older Adults
por: Grandner, Michael A., et al.
Publicado: (2019)

Polypharmacy in the HIV-infected older adult population
por: Gleason, Lauren J, et al.
Publicado: (2013)

Factors associated with excessive polypharmacy in older people
por: Walckiers, Denise, et al.
Publicado: (2015)

Polypharmacy in the Older Adult: Medication Review in the Community
por: Pacetti, Staci, et al.
Publicado: (2020)

Prevalence and impact of polypharmacy in older patients with type 2 diabetes
por: Remelli, Francesca, et al.
Publicado: (2022)

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
por: Urbańczyk, Kamila, et al.
Publicado: (2023)

A Drug Safety Concept (I) to Avoid Polypharmacy Risks in Transplantation by Individual Pharmacotherapy Management in Therapeutic Drug Monitoring of Immunosuppressants
por: Wolf, Ursula
Publicado: (2023)

Correction: Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review
por: Turk, Amadea, et al.
Publicado: (2022)

Underdiagnosed CKD in Geriatric Trauma Patients and Potent Prevention of Renal Impairment from Polypharmacy Risks through Individual Pharmacotherapy Management (IPM-III)
por: Wolf, Ursula, et al.
Publicado: (2023)

Optimising Clinical Trial Design in Older Cancer Patients
por: Whelehan, Shóna, et al.
Publicado: (2018)

Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings
por: Whitman, Andrew, et al.
Publicado: (2021)

Determinants and consequences of polypharmacy in patients with a depressive disorder in later life
por: Wiersema, Carlijn, et al.
Publicado: (2022)

Pharmacotherapy of Pain in the Older Population: The Place of Opioids
por: Prostran, Milica, et al.
Publicado: (2016)

Topical Pharmacotherapy for Actinic Keratoses in Older Adults
por: Calzavara-Pinton, Piergiacomo, et al.
Publicado: (2022)

Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
por: Matera, Maria Gabriella, et al.
Publicado: (2023)

Polypharmacy in Older Adults: The Role of the Advanced Practitioner in Oncology
por: Cope, Diane G.
Publicado: (2013)

Polypharmacy among Underserved Older African American Adults
por: Bazargan, Mohsen, et al.
Publicado: (2017)

The Need for Actions Against Polypharmacy in Older People With Frailty
por: Kojima, Taro
Publicado: (2018)

Adverse Outcomes, Polysubstance Use, and Polypharmacy in Older Veterans
por: Byers, Amy
Publicado: (2020)

Polypharmacy in older adults with HIV infection: Effects on the brain
por: Smith, Lauren, et al.
Publicado: (2021)

Polypharmacy in older patients: identifying the need for support by a community pharmacist
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2019)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Idiopathic gigantomastia in a patient on polypharmacy
por: Nguyen, Ngoc-Nhu Jennifer, et al.
Publicado: (2021)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Impact of clinical pharmacist’s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study
por: Stuhec, Matej, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q6ds0pk4v90uod3devbs42e94l